Skip to content
Try Mental Wellness – Lifestyle
Author:
Continuity Biosciences LLC
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
May 20, 2026
Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
March 24, 2026